180 related articles for article (PubMed ID: 14662257)
21. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Carlson J; Platonov PG; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Am J Cardiol; 2013 Jan; 111(2):225-30. PubMed ID: 23111138
[TBL] [Abstract][Full Text] [Related]
22. Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.
Mulder BA; van Veldhuisen DJ; Crijns HJ; Böhm M; Cohen-Solal A; Babalis D; Roughton M; Flather MD; Coats AJ; Van Gelder IC
Eur J Heart Fail; 2012 Oct; 14(10):1171-8. PubMed ID: 22764183
[TBL] [Abstract][Full Text] [Related]
23. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Eur Heart J; 2014 Feb; 35(8):517-24. PubMed ID: 24135831
[TBL] [Abstract][Full Text] [Related]
24. Rhythm control versus rate control for atrial fibrillation and heart failure.
Roy D; Talajic M; Nattel S; Wyse DG; Dorian P; Lee KL; Bourassa MG; Arnold JM; Buxton AE; Camm AJ; Connolly SJ; Dubuc M; Ducharme A; Guerra PG; Hohnloser SH; Lambert J; Le Heuzey JY; O'Hara G; Pedersen OD; Rouleau JL; Singh BN; Stevenson LW; Stevenson WG; Thibault B; Waldo AL;
N Engl J Med; 2008 Jun; 358(25):2667-77. PubMed ID: 18565859
[TBL] [Abstract][Full Text] [Related]
25. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
Allen LA; Fonarow GC; Simon DN; Thomas LE; Marzec LN; Pokorney SD; Gersh BJ; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Chang P; Peterson ED; Piccini JP;
J Am Coll Cardiol; 2015 Jun; 65(25):2691-8. PubMed ID: 26112191
[TBL] [Abstract][Full Text] [Related]
26. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate.
Hofmann R; Steinwender C; Kammler J; Kypta A; Leisch F
Int J Cardiol; 2006 Jun; 110(1):27-32. PubMed ID: 16046015
[TBL] [Abstract][Full Text] [Related]
27. Chronic atrial fibrillation: a systematic review of medical heart rate control management.
Nikolaidou T; Channer KS
Postgrad Med J; 2009 Jun; 85(1004):303-12. PubMed ID: 19528305
[TBL] [Abstract][Full Text] [Related]
28. Rate control and quality of life in patients with permanent atrial fibrillation: the Quality of Life and Atrial Fibrillation (QOLAF) Study.
Tsuneda T; Yamashita T; Fukunami M; Kumagai K; Niwano S; Okumura K; Inoue H
Circ J; 2006 Aug; 70(8):965-70. PubMed ID: 16864926
[TBL] [Abstract][Full Text] [Related]
29. Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
Kotecha D; Flather MD; Altman DG; Holmes J; Rosano G; Wikstrand J; Packer M; Coats AJS; Manzano L; Böhm M; van Veldhuisen DJ; Andersson B; Wedel H; von Lueder TG; Rigby AS; Hjalmarson Å; Kjekshus J; Cleland JGF;
J Am Coll Cardiol; 2017 Jun; 69(24):2885-2896. PubMed ID: 28467883
[TBL] [Abstract][Full Text] [Related]
30. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.
Fromm C; Suau SJ; Cohen V; Likourezos A; Jellinek-Cohen S; Rose J; Marshall J
J Emerg Med; 2015 Aug; 49(2):175-82. PubMed ID: 25913166
[TBL] [Abstract][Full Text] [Related]
31. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
[TBL] [Abstract][Full Text] [Related]
32. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
Van Gelder IC; Van Veldhuisen DJ; Crijns HJ; Tuininga YS; Tijssen JG; Alings AM; Bosker HA; Cornel JH; Kamp O; Veeger NJ; Volbeda M; Rienstra M; Ranchor AV; TenVergert EM; Van den Berg MP
Am Heart J; 2006 Sep; 152(3):420-6. PubMed ID: 16923407
[TBL] [Abstract][Full Text] [Related]
33. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
[TBL] [Abstract][Full Text] [Related]
34. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
[TBL] [Abstract][Full Text] [Related]
36. Amiodarone versus sotalol for atrial fibrillation.
Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD;
N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201
[TBL] [Abstract][Full Text] [Related]
37. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Le Heuzey JY; De Ferrari GM; Radzik D; Santini M; Zhu J; Davy JM
J Cardiovasc Electrophysiol; 2010 Jun; 21(6):597-605. PubMed ID: 20384650
[TBL] [Abstract][Full Text] [Related]
38. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
; Connolly S; Pogue J; Hart R; Pfeffer M; Hohnloser S; Chrolavicius S; Pfeffer M; Hohnloser S; Yusuf S
Lancet; 2006 Jun; 367(9526):1903-12. PubMed ID: 16765759
[TBL] [Abstract][Full Text] [Related]
39. [Comparison between digoxin and atenolol in chronic atrial fibrillation].
Lanas F; Salvatici R; Castillo G; Montecinos A; Stockins B; Molina E
Rev Med Chil; 1995 Oct; 123(10):1252-62. PubMed ID: 8733316
[TBL] [Abstract][Full Text] [Related]
40. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.
Uretsky BF; Young JB; Shahidi FE; Yellen LG; Harrison MC; Jolly MK
J Am Coll Cardiol; 1993 Oct; 22(4):955-62. PubMed ID: 8409069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
